Caliper, DxTerity Partner on Assays for LabChip Dx Platform | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – DxTerity Diagnostics and Caliper Life Sciences today announced a deal that will allow researchers to perform DxTerity's NEAT multiplex diagnostic assays on Caliper's LabChip Dx instrument platform.

The co-development and co-marketing deal also includes the development by the firms of specific diagnostic identification, scoring, and reporting software.

Financial and other terms were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: SNP reference panel from the Haplotype Reference Consortium, and more.

Halloran Consulting's Laurie Halloran lists at Stat News the mistakes she sees startup companies make when pursuing a clinical trial.

MIT researchers are using bees to collect and visualize urban microbiome samples, Wired reports.

Reliance on Excel leads to errors in gene name lists, a new Genome Biology paper reports.